Literature DB >> 3746363

Polymorphonuclear pleocytosis in the cerebrospinal fluid during chemotherapy for tuberculous meningitis.

R Teoh, G O'Mahony, V T Yeung.   

Abstract

Five patients on chemotherapy for tuberculous meningitis developed sudden and unexpected cerebrospinal fluid pleocytosis consisting predominantly of polymorphonuclear leucocytes. The cellular changes, which developed 4-108 days after starting treatment, were not accompanied by an alteration in the clinical state and disappeared within a week whether or not an additional antibiotic was prescribed. Through the cause is uncertain, possible mechanisms are discussed. We are prompted to report these cases because the cytological changes are not well recognised and may cause difficulties in management.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3746363     DOI: 10.1007/bf00314027

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

Review 1.  TUBERCULOUS MENINGITIS.

Authors:  H V SMITH
Journal:  Int J Neurol       Date:  1964

2.  The present status of the treatment of tuberculosis of the central nervous system.

Authors:  M H LEPPER; H W SPIES
Journal:  Ann N Y Acad Sci       Date:  1963-02-28       Impact factor: 5.691

3.  Treatment of tuberculous meningitis.

Authors:  J LORBER
Journal:  Br Med J       Date:  1960-04-30

4.  Value of repeat lumbar puncture in the differential diagnosis of meningitis.

Authors:  R D Feigin; P G Shackelford
Journal:  N Engl J Med       Date:  1973-09-13       Impact factor: 91.245

5.  Neurological complications of tuberculosis: some unusual manifestations.

Authors:  R S Kocen; M Parsons
Journal:  Q J Med       Date:  1970-01

6.  Evaluation of intrathecal therapy with streptomycin and hydrocortisone in tuberculous meningitis.

Authors:  I Freiman; J Geefhuysen
Journal:  J Pediatr       Date:  1970-06       Impact factor: 4.406

7.  Paradoxical expansion of intracranial tuberculomas during chemotherapy.

Authors:  S T Chambers; W A Hendrickse; C Record; P Rudge; H Smith
Journal:  Lancet       Date:  1984-07-28       Impact factor: 79.321

8.  Cerebral tuberculomas developing during treatment of tuberculous meningitis.

Authors:  A J Lees; A F MacLeod; J Marshall
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

9.  Tuberculous meningitis in Nigerians. A study of 194 patients.

Authors:  B O Osuntokun; A O Adeuja; J B Familusi
Journal:  Trop Geogr Med       Date:  1971-09

10.  THE ROLE OF HYPERSENSITIVITY IN THE PRODUCTION OF EXPERIMENTAL MENINGITIS : I. EXPERIMENTAL MENINGITIS IN TUBERCULOUS ANIMALS.

Authors:  C G Burn; K H Finley
Journal:  J Exp Med       Date:  1932-07-31       Impact factor: 14.307

  10 in total
  4 in total

1.  Treatment-Associated Inflammatory Deterioration in Tuberculous Meningitis: Unpicking the Paradox.

Authors:  Nguyen Thuy Thuong Thuong; Guy E Thwaites
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

2.  Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis.

Authors:  Anurag Kumar Singh; Hardeep Singh Malhotra; Ravindra Kumar Garg; Amita Jain; Neeraj Kumar; Neera Kohli; Rajesh Verma; Praveen Kumar Sharma
Journal:  BMC Infect Dis       Date:  2016-06-21       Impact factor: 3.090

Review 3.  The Use of Adjunctive Steroids in Central Nervous Infections.

Authors:  Shalini Gundamraj; Rodrigo Hasbun
Journal:  Front Cell Infect Microbiol       Date:  2020-11-23       Impact factor: 5.293

4.  Paradoxical Manifestation is Common in HIV-negative Tuberculous Meningitis.

Authors:  Mei-Ling Sharon Tai; Hazman Mohd Nor; Khairul Azmi Abdul Kadir; Shanthi Viswanathan; Kartini Rahmat; Norzaini Rose Mohd Zain; Kuo Ghee Ong; Mohd Hanip Rafia; Chong Tin Tan
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.